Tag: Hēlo thrombectomy system
Endovascular Engineering receives two US FDA 510(k) clearances for PE thrombectomy...
Endovascular Engineering (E2) recently announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for both the Hēlo thrombectomy system and...
Endovascular Engineering’s ENGULF pivotal trial completes patient enrolment
Endovascular Engineering (E2) has completed patient enrolment in the pivotal cohort of its ENGULF trial, involving the Hēlo pulmonary embolism (PE) thrombectomy system.
The investigational...
E2 shares positive initial results from use of Hēlo system for...
Endovascular Engineering (E2) has announced positive initial results from its ENGULF study, demonstrating successful outcomes among the first 15 patients evaluated in the trial...
